Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Heart Failure | Research

Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data

Authors: Chenliang Ge, Zhiyuan Jiang, Binghua Long, Qingjian Lu, Yan He

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

This study explored the association of cardiovascular disease (CVD) with cancer mortality risk in individuals with or without a history of cancer, to better understand the interplay between CVD and cancer outcomes.

Methods

Utilizing data from the National Health and Nutrition Examination Survey (NHANES) spanning 1999 to 2018, a retrospective cohort analysis was conducted. This analysis accounted for the survey’s complex design to ensure national representativeness. The association of CVD with cancer mortality was assessed through multivariable Cox proportional hazards models.

Results

The present study included 59,653 participants, of whom 54,095 did not have cancer and 5558 had a history of cancer. In individuals without cancer, heart failure (HF) was associated with an increased risk of mortality from cancer (HR, 1.36; 95% CI, 1.09–1.69; P = 0.005). In participants with cancer, HF correlated with a higher risk of mortality from cancer (HR, 1.76; 95% CI, 1.32–2.34; P < 0.001). Diabetes (DM), hypertension (HBP) and coronary heart disease (CHD) were not significantly associated with an increased risk of mortality from cancer. Significant differences were observed in the interaction between cancer and CHD (HR, 0.68; 95% CI, 0.53–0.87; P = 0.002). For cancer and HBP, a similar trend was noted (HR, 0.75; 95% CI, 0.62–0.91; P = 0.003). No significant differences were found in interactions between HF, DM and cancer.

Conclusions

HF was associated with an increased risk of mortality from cancer, regardless of cancer history, while HBP, CHD and DM showed no significant association. These findings underscore the importance of understanding the mechanisms behind the increased risk of cancer mortality following HF.
Appendix
Available only for authorised users
Literature
3.
go back to reference Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Syst. 2017;66(6):1–75. Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Syst. 2017;66(6):1–75.
4.
go back to reference Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clinic proceedings 2014;89(9):1287–1306. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clinic proceedings 2014;89(9):1287–1306.
5.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef
6.
go back to reference Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals Oncology: Official J Eur Soc Med Oncol. 2003;14(Suppl 5):v128–149.CrossRef Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Annals Oncology: Official J Eur Soc Med Oncol. 2003;14(Suppl 5):v128–149.CrossRef
7.
go back to reference Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the silver tsunami: prevalence trajectories and Comorbidity Burden among Older Cancer survivors in the United States. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. Cosponsored Am Soc Prev Oncol. 2016;25(7):1029–36. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the silver tsunami: prevalence trajectories and Comorbidity Burden among Older Cancer survivors in the United States. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research. Cosponsored Am Soc Prev Oncol. 2016;25(7):1029–36.
8.
go back to reference de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019;21(12):1515–25.CrossRefPubMed de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019;21(12):1515–25.CrossRefPubMed
10.
go back to reference Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229–361.CrossRefPubMed Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229–361.CrossRefPubMed
11.
go back to reference Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768–801.CrossRefPubMed Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768–801.CrossRefPubMed
12.
go back to reference Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, Van der Meer P, Cohen Solal A, Zamorano JL, Jerusalem G, Moonen M, et al. Cardio-oncology services: rationale, organization, and implementation. Eur Heart J. 2019;40(22):1756–63.CrossRefPubMed Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, Van der Meer P, Cohen Solal A, Zamorano JL, Jerusalem G, Moonen M, et al. Cardio-oncology services: rationale, organization, and implementation. Eur Heart J. 2019;40(22):1756–63.CrossRefPubMed
13.
go back to reference del Pozo Cruz B, Ahmadi MN, Lee I-M, Stamatakis E. Prospective associations of Daily Step counts and Intensity with Cancer and Cardiovascular Disease incidence and mortality and all-cause mortality. JAMA Intern Med. 2022;182(11):1139–48.CrossRefPubMedPubMedCentral del Pozo Cruz B, Ahmadi MN, Lee I-M, Stamatakis E. Prospective associations of Daily Step counts and Intensity with Cancer and Cardiovascular Disease incidence and mortality and all-cause mortality. JAMA Intern Med. 2022;182(11):1139–48.CrossRefPubMedPubMedCentral
14.
go back to reference Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat Reviews Cardiol. 2022;19(2):133–43.CrossRef Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Epidemiology of cardiovascular disease in Europe. Nat Reviews Cardiol. 2022;19(2):133–43.CrossRef
15.
go back to reference Wang Y, Liu B, Han H, Hu Y, Zhu L, Rimm EB, Hu FB, Sun Q. Associations between plant-based dietary patterns and risks of type 2 diabetes, cardiovascular disease, cancer, and mortality– a systematic review and meta-analysis. Nutr J. 2023;22(1):46.CrossRefPubMedPubMedCentral Wang Y, Liu B, Han H, Hu Y, Zhu L, Rimm EB, Hu FB, Sun Q. Associations between plant-based dietary patterns and risks of type 2 diabetes, cardiovascular disease, cancer, and mortality– a systematic review and meta-analysis. Nutr J. 2023;22(1):46.CrossRefPubMedPubMedCentral
16.
go back to reference Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, Carroll MD, Hirsch R, Schober S, Johnson CL. The National Health and Nutrition Examination Survey: Sample Design, 1999–2006. Vital and health statistics Series 2, Data evaluation and methods research 2012(155):1–39. Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB, Carroll MD, Hirsch R, Schober S, Johnson CL. The National Health and Nutrition Examination Survey: Sample Design, 1999–2006. Vital and health statistics Series 2, Data evaluation and methods research 2012(155):1–39.
17.
go back to reference Curtin LR, Mohadjer LK, Dohrmann SM, Kruszon-Moran D, Mirel LB, Carroll MD, Hirsch R, Burt VL, Johnson CL. National Health and Nutrition Examination Survey: sample design, 2007–2010. Vital Health Stat Ser 2 Data Evaluation Methods Res 2013(160):1–23. Curtin LR, Mohadjer LK, Dohrmann SM, Kruszon-Moran D, Mirel LB, Carroll MD, Hirsch R, Burt VL, Johnson CL. National Health and Nutrition Examination Survey: sample design, 2007–2010. Vital Health Stat Ser 2 Data Evaluation Methods Res 2013(160):1–23.
18.
go back to reference Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011–2014. Vital Health Stat Ser 2 Data Evaluation Methods Res 2014(162):1–33. Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011–2014. Vital Health Stat Ser 2 Data Evaluation Methods Res 2014(162):1–33.
19.
go back to reference Chen TC, Clark J, Riddles MK, Mohadjer LK, Fakhouri THI. National Health and Nutrition Examination Survey, 2015–2018: Sample Design and Estimation procedures. Vital Health Stat Ser 2 Data Evaluation Methods Res 2020(184):1–35. Chen TC, Clark J, Riddles MK, Mohadjer LK, Fakhouri THI. National Health and Nutrition Examination Survey, 2015–2018: Sample Design and Estimation procedures. Vital Health Stat Ser 2 Data Evaluation Methods Res 2020(184):1–35.
20.
go back to reference Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci data. 2016;3:160096.CrossRefPubMedPubMedCentral Patel CJ, Pho N, McDuffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci data. 2016;3:160096.CrossRefPubMedPubMedCentral
22.
go back to reference Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat Ser 2 Data Evaluation Methods Res 2013(161):1–24. Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat Ser 2 Data Evaluation Methods Res 2013(161):1–24.
23.
go back to reference Pan S, Chen S. Empirical Comparison of Imputation Methods for Multivariate Missing Data in Public Health. Int J Environ Res Public Health 2023, 20(2). Pan S, Chen S. Empirical Comparison of Imputation Methods for Multivariate Missing Data in Public Health. Int J Environ Res Public Health 2023, 20(2).
24.
go back to reference Riley JP, Beattie JM. Palliative care in heart failure: facts and numbers. ESC Heart Fail. 2017;4(2):81–7.CrossRefPubMed Riley JP, Beattie JM. Palliative care in heart failure: facts and numbers. ESC Heart Fail. 2017;4(2):81–7.CrossRefPubMed
25.
26.
go back to reference Saitoh M, Dos Santos MR, Emami A, Ishida J, Ebner N, Valentova M, Bekfani T, Sandek A, Lainscak M, Doehner W, et al. Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). ESC Heart Fail. 2017;4(4):448–57.CrossRefPubMedPubMedCentral Saitoh M, Dos Santos MR, Emami A, Ishida J, Ebner N, Valentova M, Bekfani T, Sandek A, Lainscak M, Doehner W, et al. Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). ESC Heart Fail. 2017;4(4):448–57.CrossRefPubMedPubMedCentral
27.
go back to reference von Haehling S. Co-morbidities in heart failure beginning to sprout-and no end in sight? Eur J Heart Fail. 2017;19(12):1566–8.CrossRef von Haehling S. Co-morbidities in heart failure beginning to sprout-and no end in sight? Eur J Heart Fail. 2017;19(12):1566–8.CrossRef
28.
go back to reference Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC. Association of CKD and cancer risk in older people. J Am Soc Nephrology: JASN. 2009;20(6):1341–50.CrossRefPubMedCentral Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC. Association of CKD and cancer risk in older people. J Am Soc Nephrology: JASN. 2009;20(6):1341–50.CrossRefPubMedCentral
29.
go back to reference Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Cerhan JR, Roger VL. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013;62(10):881–6.CrossRefPubMedPubMedCentral Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Cerhan JR, Roger VL. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013;62(10):881–6.CrossRefPubMedPubMedCentral
30.
go back to reference Hasin T, Gerber Y, Weston SA, Jiang R, Killian JM, Manemann SM, Cerhan JR, Roger VL. Heart failure after myocardial infarction is Associated with increased risk of Cancer. J Am Coll Cardiol. 2016;68(3):265–71.CrossRefPubMedPubMedCentral Hasin T, Gerber Y, Weston SA, Jiang R, Killian JM, Manemann SM, Cerhan JR, Roger VL. Heart failure after myocardial infarction is Associated with increased risk of Cancer. J Am Coll Cardiol. 2016;68(3):265–71.CrossRefPubMedPubMedCentral
31.
go back to reference Banke A, Schou M, Videbaek L, Møller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Køber L, Hildebrandt PR, Gislason GH. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail. 2016;18(3):260–6.CrossRefPubMed Banke A, Schou M, Videbaek L, Møller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, Køber L, Hildebrandt PR, Gislason GH. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail. 2016;18(3):260–6.CrossRefPubMed
32.
go back to reference Malhotra J, Boffetta P. Association of increased Cancer risk with heart failure. J Am Coll Cardiol. 2016;68(3):272–3.CrossRefPubMed Malhotra J, Boffetta P. Association of increased Cancer risk with heart failure. J Am Coll Cardiol. 2016;68(3):272–3.CrossRefPubMed
33.
go back to reference Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, Jong Sd, Haubner BJ, Nagengast WB, Lyon AR, Vegt Bvd. Heart failure stimulates Tumor Growth by circulating factors. Circulation. 2018;138(7):678–91.CrossRefPubMed Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, Jong Sd, Haubner BJ, Nagengast WB, Lyon AR, Vegt Bvd. Heart failure stimulates Tumor Growth by circulating factors. Circulation. 2018;138(7):678–91.CrossRefPubMed
34.
go back to reference Cuomo A, Pirozzi F, Attanasio U, Franco R, Elia F, De Rosa E, Russo M, Ghigo A, Ameri P, Tocchetti CG, et al. Cancer Risk in the Heart failure Population: Epidemiology, mechanisms, and clinical implications. Curr Oncol Rep. 2020;23(1):7.CrossRefPubMedPubMedCentral Cuomo A, Pirozzi F, Attanasio U, Franco R, Elia F, De Rosa E, Russo M, Ghigo A, Ameri P, Tocchetti CG, et al. Cancer Risk in the Heart failure Population: Epidemiology, mechanisms, and clinical implications. Curr Oncol Rep. 2020;23(1):7.CrossRefPubMedPubMedCentral
35.
go back to reference Soman A, Asha Nair S. Unfolding the cascade of SERPINA3: inflammation to cancer. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2022;1877(5):188760.CrossRef Soman A, Asha Nair S. Unfolding the cascade of SERPINA3: inflammation to cancer. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2022;1877(5):188760.CrossRef
36.
go back to reference Ausoni S, Azzarello G. Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork. Frontiers in cardiovascular medicine 2020, 7. Ausoni S, Azzarello G. Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork. Frontiers in cardiovascular medicine 2020, 7.
37.
go back to reference Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzuki T. Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021;234:71–80.CrossRefPubMed Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzuki T. Association of gut-related metabolites with outcome in acute heart failure. Am Heart J. 2021;234:71–80.CrossRefPubMed
38.
go back to reference Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.CrossRefPubMedPubMedCentral Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–52.CrossRefPubMedPubMedCentral
39.
go back to reference van Bilsen M, Patel HC, Bauersachs J, Böhm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, et al. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2017;19(11):1361–78.CrossRefPubMed van Bilsen M, Patel HC, Bauersachs J, Böhm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, et al. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2017;19(11):1361–78.CrossRefPubMed
40.
go back to reference Cho IJ, Shin JH, Jung MH, Kang CY, Hwang J, Kwon CH, Kim W, Kim DH, Lee CJ, Kang SH et al. Antihypertensive drugs and the risk of Cancer: a Nationwide Cohort Study. J Clin Med 2021, 10(4). Cho IJ, Shin JH, Jung MH, Kang CY, Hwang J, Kwon CH, Kim W, Kim DH, Lee CJ, Kang SH et al. Antihypertensive drugs and the risk of Cancer: a Nationwide Cohort Study. J Clin Med 2021, 10(4).
41.
42.
go back to reference Ricco N, Kron SJ. Statins in Cancer Prevention and Therapy. Cancers 2023, 15(15). Ricco N, Kron SJ. Statins in Cancer Prevention and Therapy. Cancers 2023, 15(15).
43.
go back to reference Jiang W, Hu J-W, He X-R, Jin W-L, He X-Y. Statins: a repurposed drug to fight cancer. J Experimental Clin Cancer Res. 2021;40(1):241.CrossRef Jiang W, Hu J-W, He X-R, Jin W-L, He X-Y. Statins: a repurposed drug to fight cancer. J Experimental Clin Cancer Res. 2021;40(1):241.CrossRef
44.
go back to reference Zhou Q, Jiao Z, Liu Y, Devreotes PN, Zhang Z. The effects of statins in patients with advanced-stage cancers - a systematic review and meta-analysis. Front Oncol 2023, 13. Zhou Q, Jiao Z, Liu Y, Devreotes PN, Zhang Z. The effects of statins in patients with advanced-stage cancers - a systematic review and meta-analysis. Front Oncol 2023, 13.
45.
go back to reference Matusewicz L, Czogalla A, Sikorski AF. Attempts to use statins in cancer therapy: an update. Tumor Biology. 2020;42(7):1010428320941760.CrossRefPubMed Matusewicz L, Czogalla A, Sikorski AF. Attempts to use statins in cancer therapy: an update. Tumor Biology. 2020;42(7):1010428320941760.CrossRefPubMed
Metadata
Title
Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data
Authors
Chenliang Ge
Zhiyuan Jiang
Binghua Long
Qingjian Lu
Yan He
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18498-7

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue